Cyclophosphamide, Docetaxel, Doxorubicin, Fluorouracil, Pertuzumab, and Trastuzumab
About
Membership operator: AND
Therapies: 6
Therapies
Cyclophosphamide (tx:ncit:C405)
Docetaxel (tx:ncit:C1526)
Doxorubicin (tx:ncit:C456)
Fluorouracil (tx:ncit:C505)
Pertuzumab (tx:ncit:C38692)
Trastuzumab (tx:ncit:C1647)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (4) | HER2-positive | Invasive Breast Carcinoma | Cyclophosphamide, Docetaxel, Doxorubicin, Fluorouracil, Pertuzumab, Trastuzumab |